α-lipoic acid prevents 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity

被引:79
|
作者
Aguirre, N [1 ]
Barrionuevo, M [1 ]
Ramírez, MJ [1 ]
Del Río, J [1 ]
Lasheras, B [1 ]
机构
[1] Univ Navarra, Sch Med, Dept Pharmacol, Pamplona 31008, Spain
关键词
5-HT (serotonin; 5-hydroxytryptamine); glial fibrillary acidic protein (GFAP); alpha-lipoic acid (thioctic acid); 3,4-methylenedioxymethamphetamine (MDMA; Ecstasy);
D O I
10.1097/00001756-199911260-00039
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
A single administration of 3,4-methylenedioxymethamphetamine (MDMA, 20 mg/kg, i.p.), induced significant hyperthermia in rats and reduced 5-hydroxytryptamine (5-HT) content and [H-3]paroxetine-labeled 5-HT transporter density in the frontal cortex, striatum and hippocampus by 40-60% 1 week later, MDMA treatment also increased glial fibrillary acidic protein (GFAP) immunoreactivity in the hippocampus. Repeated administration of the metabolic antioxidant alpha-lipoic acid (100 mg/kg, i.p., b.i.d. for 2 consecutive days) 30 min prior to MDMA did not prevent the acute hyperthermia induced by the drug; however, it fully prevented the serotonergic deficits and the changes in the glial response induced by MDMA. These results further support the hypothesis that free radical formation is responsible for MDMA-induced neurotoxicity. (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:3675 / 3680
页数:6
相关论文
共 50 条
  • [31] The cardiovascular effects of ecstasy (3,4-methylenedioxymethamphetamine, MDMA)
    Lester, SJ
    Baggott, MJ
    Viloria, EM
    Welm, S
    Schiller, NB
    Mendelson, J
    Jones, RT
    Foster, E
    [J]. CIRCULATION, 1999, 100 (18) : 575 - 575
  • [32] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    [J]. DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [33] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
    Montgomery, H
    Myerson, S
    [J]. AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
  • [34] Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA)
    Curry, Daniel W.
    Berro, Lais F.
    Belkoff, Andie R.
    Sulima, Agnieszka
    Rice, Kenner C.
    Howell, Leonard L.
    [J]. NEUROPHARMACOLOGY, 2019, 151 : 13 - 20
  • [35] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    [J]. JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433
  • [36] SEROTONIN NEUROTOXICITY AFTER (+/-)3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA ECSTASY) - A CONTROLLED-STUDY IN HUMANS
    MCCANN, UD
    RIDENOUR, A
    SHAHAM, Y
    RICAURTE, GA
    [J]. NEUROPSYCHOPHARMACOLOGY, 1994, 10 (02) : 129 - 138
  • [37] Metformin Prevented Dopaminergic Neurotoxicity Induced by 3,4-Methylenedioxymethamphetamine Administration
    Porceddu, Pier Francesca
    Ishola, Ismail Ogunbayode
    Contu, Liliana
    Morelli, Micaela
    [J]. NEUROTOXICITY RESEARCH, 2016, 30 (01) : 101 - 109
  • [38] (±)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity:: Studies in animals
    Ricaurte, GA
    Yuan, J
    McCann, UD
    [J]. NEUROPSYCHOBIOLOGY, 2000, 42 (01) : 5 - 10
  • [39] (±)3,4-methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity:: Clinical studies
    McCann, UD
    Eligulashvili, V
    Ricaurte, GA
    [J]. NEUROPSYCHOBIOLOGY, 2000, 42 (01) : 11 - 16
  • [40] Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats
    Shioda, Katsutoshi
    Nisijima, Koichi
    Yoshino, Tatsuki
    Kuboshima, Kyoko
    Iwamura, Tatsunori
    Yui, Kunio
    Kato, Satoshi
    [J]. NEUROTOXICOLOGY, 2008, 29 (06) : 1030 - 1036